Skip to content
10-Q

Quarterly Report

Harvard Apparatus Regenerative Technology, Inc. HRGN

0001493152-24-031570

← back to feed
Filed
Aug 13, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 5, 2024 14.53M sh
Shares Diluted Q2 2024 · Jun 30, 2024 14.26M sh
Shares Diluted Q2 2024 · Jun 30, 2024 14.1M sh
Shares Diluted Q2 2024 · Jun 30, 2023 13.79M sh
Shares Diluted Q2 2024 · Jun 30, 2023 13M sh
Cash And Equivalents Q2 2024 · Jun 30, 2024 $139K
Cash And Equivalents Q2 2024 · Dec 31, 2023 $432K
Current Liabilities Q2 2024 · Jun 30, 2024 $1.99M
Current Liabilities Q2 2024 · Dec 31, 2023 $968K
Total Liabilities Q2 2024 · Jun 30, 2024 $2.02M
Total Liabilities Q2 2024 · Dec 31, 2023 $1.41M
Current Assets Q2 2024 · Jun 30, 2024 $656K
Current Assets Q2 2024 · Dec 31, 2023 $783K
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.18
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.32
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.19
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.43
Total Assets Q2 2024 · Dec 31, 2023 $2.61M
Capex Q2 2024 · Jun 30, 2023 $11K
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$2.56M
Stockholders Equity Q2 2024 · Jun 30, 2023 $3.8M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$1.06M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$3.19M
Eps Basic Q2 2024 · Jun 30, 2023 −$0.19
Eps Basic Q2 2024 · Jun 30, 2023 −$0.43
Rd Expense Q2 2024 · Jun 30, 2023 $1.57M
Rd Expense Q2 2024 · Jun 30, 2023 $2.08M
Net Income Q2 2024 · Jun 30, 2023 −$2.61M
Net Income Q2 2024 · Jun 30, 2023 −$5.5M
Operating Income Q2 2024 · Jun 30, 2023 −$2.65M
Operating Income Q2 2024 · Jun 30, 2023 −$5.54M